Detalhe da pesquisa
1.
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab.
J Transl Med;
13: 106, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25890004
2.
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations.
J Transl Med;
9: 76, 2011 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21609436
3.
Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection.
Clin Cancer Res;
24(1): 158-168, 2018 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29061642
4.
Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival.
PLoS One;
11(9): e0163149, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27643613
5.
Next-generation sequencing: hype and hope for development of personalized radiation therapy?
Radiat Oncol;
10: 183, 2015 Aug 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26316159
6.
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
PLoS One;
9(6): e98867, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24927258
7.
Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells.
Radiother Oncol;
101(1): 158-64, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21665310